Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on Oct 14, 2020 11:21pm

133 Views

Post# 31719192

RE:RE:RE:RE:re update etc.

Not bad volume/accumulation in the last week. I thought the presentation was well done its nice to see how it's coming along with a new focus on immune protection and cells. With multiple options for both. I think it's important to remember the thesis here has always been the cell pouch is the crux and it's been Sernova's focus. Now we are seeing a new focus that indicates behind the scenes the pouch is progressing well and now its an all in effort to prove up the other 2 components. I feel this could get very interesting as there are other players with cells and or immune protection providing multiple M&A opportunities.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?